Cyanoguanidine compounds

Details Cyanoguanidine compounds Cyanoguanidine compounds

2005-12-20

2011-11-08

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S323000, C546S162000, C546S264000

Reexamination Certificate

active

08053446

ABSTRACT:
Novel pyridyl cyanoguanidine compounds of general formula I (I) wherein R1, X, R2and R3are as defined herein, exhibit a high antiproliferative activity and may be used in the treatment of hyperproliferative and neo-plastic diseases.

REFERENCES:
patent: 5696140 (1997-12-01), Bramm et al.
patent: 5919816 (1999-07-01), Hausheer et al.
patent: 6346541 (2002-02-01), Hunneche
patent: 6525077 (2003-02-01), Binderup et al.
patent: 6642215 (2003-11-01), Madsen et al.
patent: 6645968 (2003-11-01), Altenbach et al.
patent: 7129043 (2006-10-01), Boustany et al.
patent: 7253193 (2007-08-01), Binderup et al.
patent: 7304066 (2007-12-01), Bjorkling
patent: 7807682 (2010-10-01), Bjorkling
patent: 2003/0045515 (2003-03-01), Binderup et al.
patent: 2006/0014804 (2006-01-01), Binderup
patent: 2007/0249676 (2007-10-01), Binderup et al.
patent: 0 660 823 (1996-08-01), None
patent: WO-94/06770 (1994-03-01), None
patent: WO-98/54141 (1998-12-01), None
patent: WO-98/54142 (1998-12-01), None
patent: WO-98/54143 (1998-12-01), None
patent: WO-98/54144 (1998-12-01), None
patent: WO-98/54145 (1998-12-01), None
patent: WO-00/61559 (2000-10-01), None
patent: WO-00/61561 (2000-10-01), None
patent: WO-01/09096 (2001-02-01), None
patent: WO 01/09096 (2001-02-01), None
patent: WO-02/42265 (2002-05-01), None
patent: WO-02/62762 (2002-08-01), None
patent: WO-02/094322 (2002-11-01), None
patent: WO 02/094813 (2002-11-01), None
patent: WO-02/094813 (2002-11-01), None
patent: WO-03/097601 (2003-11-01), None
patent: WO-03/097602 (2003-11-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Bodor et al., “Soft alkylating compounds as potential antitumor agents”, Journal of Medicinal Chemistry, 1980, vol. 23, No. 5, pp. 566-569.
Boschi et al, “Nicorandil analogues containing No-Donor Furoxans and related furazans,” Bioorganic & Medical Chemistry, vol. 8, pp. 1727-1732 (2000).
Chen Jianyong et al., “Synthesis of Potassium Channel Opener Pinacidil and its Analogues,” Journal of China Pharmaceutical University, vol. 24, No. 4, 1993, pp. 202-204, SP002902627.
Davidsen et al., “N-(acyloxyalkyl) pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist,” Journal of Medicinal Chemistry, Dec. 23, 1994, vol. 37, No. 26, pp. 4423-4429.
Hjarnaa et al., CHS 828, a Novel Pyridyl Cyanoguanidine with Potent Antitumor Activity in Vitro and in vivo, Cancer Research, 59, 5751-5757, Nov. 15, 1999.
Martinsson et al., “The Combination of the antitumoural pyridyl cyanoguanidine CHS 828 and etoposide in vitro—from cytotoxic synergy to complete inhibition of apoptosis,” British journal of Pharmacology, vol. 137, pp. 568-573 (2002).
Moriguchi, et al. “Adaptive Least-Squares Method Applied to Structure-Activity Correlation of Hypotensive N-Alkyl-N″-cyano-N′ pyridylguanidines.” Journal of Medicinal Chemistry, vol. 23, No. 1, 20-26. 1980.
Olsen, L.S. et al., “Anticancer Agent CHS Suppresses Nuclear Facor-κB Activity in Cancer Cells through Downregulation of IKK Activity,” Int. J. Cancer, vol. 111, pp. 198-205, 2004.
Sara Ekelund et al, “Early Stimulation of Acidification rate by Novel Cytotoxic Pyridyl Cyanoguanidines in Human Tumor Cells: Comparison with m-lodobenzylguanidine,” Biochemical Pharmacology, vol. 60, pp. 839-849, (2000).
Schou, C. et al. “Novel Cyanoguanidines with Potent Oral Antitumour Activity,” Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 24, pp. 3095-3100, 1997.
Svensson, A. et al. “CHS 828 Inhibits Neuroblastoma Growth in Mice Alone and in Combination with Antiangiogenic Drugs,” Pediatric Research, vol. 51, No. 5, 2002, pp. 607-611.
International Search Report issued for International Patent Application No. PCT/DK2005/000803, filed Dec. 20, 2005.

Affiliated with

Also associated with

Rating

Cyanoguanidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyanoguanidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyanoguanidine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4305611